Grants Awarded

The number of grants awarded by the Histiocytosis Association varies each year. It is determined by a variety of factors including, but not limited to, the quality of eligible applications received and the availability of funds.

Use the filters below to see information for all of the research projects the Association has funded since 1992.

To filter by year and disease type, select the year first.

All
  • All
  • HLH/FEL/FHL
  • LCH
  • Rare Histiocytic Disorders and Other Topics

Genetic Defects in Cytolysis in Patients with Macrophage Activation Syndrome Enrolled in a Clinical Trial to Explore Interleukin-1 Blockage Therapy

Principal Investigator Randy Cron, M.D., Ph.D. University of Alabama at Birmingham Birmingham, AL USA Date of Award…

Read More

Innate T cells in Langerhan’s Cell Histiocytosis

Principal Investigator Stuart Berzins, Ph.D. Federation University Australia Ballarat, Victoria, Australia Date of Award December 2016 Amount…

Read More

MEK Inhibition in the Therapy of Histiocytic Neoplasms

Principal Investigator Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center New York, New York USA Date of…

Read More

Identification of Molecular Mechanisms Underlying Defective Cytotoxic Lymphocyte Function in Chediak-Higashi Syndrome, a Histiocytic Lysosomal Storage Disorder with Immunodeficiency

Principal Investigator Konrad Krzewski, PhD National Institute of Allergy and Infectious Diseases, National Institutes of Health Rockville,…

Read More

Genetic Dissection of the Exocytic Machinery in Cytotoxic Lymphocytes

Principal Investigator Matthias Voss, PhD Karolinska Institutet Stockholm, Sweden   Date of Award December 2015 Amount of…

Read More

Deciphering the Underlying Molecular Defects in CTL and NK Cell Cytotoxicity in FHL Patients

Principal Investigator Claudio Giraudo, PhD The Children’s Hospital of Philadelphia University of Pennsylvania Philadelphia, Pennsylvania USA Date…

Read More

The Interplay of NOTCH and MAPK Pathway in LCH

Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria   Date of Award December…

Read More

LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions

Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA   Date of Award…

Read More

Gaining Insights into the Mechanisms of Lymphocyte Cytotoxicity Underlying Hemophagocytic Lymphohistiocytosis

Principal Investigator Yenan Bryceson, PhD Karolinska Institutet, Stockholm, Sweden Date of Award December 2014 Amount of Award…

Read More